InsidersTradesSigma
Total declarations
Company
▲ Purchases (20 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
20
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Rodriguez, Guillermo Pablo, 4 - Director of Issuer. Insider active across 1 company, notably Blueberries Medical Corp.. In total, 20 filings have been logged. Breakdown: 20 buys · 0 sell. Total volume traded: €2k. Activity tracked since 13 May 2026. The latest transaction was disclosed on 7 July 2026 (10 - Acquisition or disposition in the public market). Regulator: SEDI. The full history is free.
Declarations20 total
10,000 shares@ CA$0.0139Common SharesTSXSEDI:4751248
Ideal exit: 3 Apr 2027 (T+270)
10,000 shares@ CA$0.0097Common SharesTSXSEDI:4751246
Ideal exit: 3 Apr 2027 (T+270)
5,000 shares@ CA$0.0097Common SharesTSXSEDI:4751242
Ideal exit: 3 Apr 2027 (T+270)
10,000 shares@ CA$0.010.0012% mcap4.0% of flowCommon SharesTSXSEDI:4742309
Ideal exit: 27 Mar 2027 (T+270)
20,000 shares@ CA$0.00890.0022% mcap7.1% of flowCommon SharesTSXSEDI:4742308
Ideal exit: 27 Mar 2027 (T+270)
15,000 shares@ CA$0.00850.0016% mcap5.1% of flowCommon SharesTSXSEDI:4742307
Ideal exit: 27 Mar 2027 (T+270)
10,000 shares@ CA$0.01120.0014% mcap4.4% of flowCommon SharesTSXSEDI:4742306
Ideal exit: 27 Mar 2027 (T+270)
10,000 shares@ CA$0.00840.0010% mcap3.3% of flowCommon SharesTSXSEDI:4742305
Ideal exit: 27 Mar 2027 (T+270)
10,000 shares@ CA$0.01130.0009% mcap5.9% of flowCommon SharesTSXSEDI:4739390
Ideal exit: 20 Mar 2027 (T+270)
5,000 shares@ CA$0.00890.0004% mcap2.3% of flowCommon SharesTSXSEDI:4739389
Ideal exit: 20 Mar 2027 (T+270)
20,000 shares@ CA$0.01010.0017% mcap10.5% of flowCommon SharesTSXSEDI:4739388
Ideal exit: 19 Mar 2027 (T+270)
5,000 shares@ CA$0.00920.0004% mcap2.4% of flowCommon SharesTSXSEDI:4739387
Ideal exit: 19 Mar 2027 (T+270)
5,000 shares@ CA$0.00930.0004% mcap2.4% of flowCommon SharesTSXSEDI:4739386
Ideal exit: 19 Mar 2027 (T+270)
1,000 shares@ CA$0.00860.0001% mcap0.5% of flowCommon SharesTSXSEDI:4739385
Ideal exit: 7 Mar 2027 (T+270)
10,000 shares@ CA$0.010.0012% mcap6.9% of flowCommon SharesTSXSEDI:4737346
Ideal exit: 13 Mar 2027 (T+270)
20,000 shares@ CA$0.00990.0025% mcap14.7% of flowCommon SharesTSXSEDI:4734576
Ideal exit: 7 Mar 2027 (T+270)
50,000 shares@ CA$0.01290.0081% mcap47.9% of flowCommon SharesTSXSEDI:4734575
Ideal exit: 7 Mar 2027 (T+270)
40,000 shares@ CA$0.00920.0046% mcap27.3% of flowCommon SharesTSXSEDI:4734574
Ideal exit: 7 Mar 2027 (T+270)
1,000 shares@ CA$0.01230.0002% mcap9.1% of flowCommon SharesTSXSEDI:4720375
Ideal exit: 9 Feb 2027 (T+270)
10,000 shares@ CA$0.01220.0015% mcap90.9% of flowCommon SharesTSXSEDI:4720374
Ideal exit: 7 Feb 2027 (T+270)
20 of 20 declarations
About Rodriguez, Guillermo Pablo
Guillermo Pablo Rodriguez is a Director at Blueberries Medical Corp. He brings expertise in governance and corporate strategy. Rodriguez is involved in overseeing the operations and strategic initiatives of the company, aimed at enhancing performance and profitability. His commitment to innovation and sustainability is an asset to Blueberries Medical.
